Fetal tachycardia - Symptoms, Causes, Treatment & Prevention

```html

Overview

Fetal tachycardia is a condition in which a fetus’s heart rate is consistently higher than normal, usually defined as more than 160 beats per minute (bpm) for a sustained period (often >10 minutes). The normal fetal heart rate ranges from 110–160 bpm. Tachycardia can be a transient response to maternal fever or medication, but persistent tachycardia may signal an underlying fetal or maternal problem that requires close monitoring.

**Who it affects** – All pregnancies are potentially at risk, but certain groups have higher incidence, including:

• Women with infections (e.g., urinary tract infection, chorioamnionitis)
• Those taking stimulant medications (e.g., decongestants, some asthma drugs)
• Pregnancies complicated by gestational diabetes, anemia, or fetal anemia from allo‑immune disease
• Maternal hyperthyroidism or severe hypertension

**Prevalence** – Persistent fetal tachycardia is relatively uncommon, occurring in roughly 0.05–0.5 % of pregnancies (1–5 per 1,000). However, transient elevation of the fetal heart rate is observed in up to 10 % of non‑pathologic antenatal visits, often linked to maternal activity or stress.

Symptoms

Because the fetus cannot report symptoms, clinicians rely on indirect signs observed during routine prenatal visits or via maternal reporting. The “symptom list” is therefore a combination of maternal observations and findings on fetal monitoring.

Maternal‑reported signs

• Rapid fetal movements – Super‑fast kicks may suggest increased fetal activity associated with tachycardia.
• Maternal fever – Temperatures >38 °C (100.4 °F) can elevate fetal heart rate.
• Palpitations or anxiety – Mothers may feel their own heart racing, prompting a check of fetal rate.

Findings on fetal assessment

• Elevated basal fetal heart rate ≥160 bpm on Doppler or cardiotocography (CTG) for ≥10 minutes.
• Decreased variability – May accompany tachycardia if fetal hypoxia is present.
• Loss of accelerations – The normal quick rises in heart rate with movement can be blunted.
• Non‑reassuring patterns on biophysical profile (BPP) or NST (non‑stress test).

Causes and Risk Factors

Fetal tachycardia is a symptom rather than a disease. Its etiology can be grouped into maternal, fetal, and iatrogenic categories.

Maternal causes

• Infection – Bacterial (UTI, pyelonephritis), viral (influenza), or intra‑amniotic infection (chorioamnionitis) raise fetal temperature and heart rate.
• Fever – Any maternal hyperthermia (e.g., from heat exposure or medication) can cause a reflex tachycardia.
• Hyperthyroidism – Excess thyroid hormone crosses the placenta, stimulating fetal metabolism.
• Maternal anemia – Reduces oxygen delivery, prompting fetal compensatory tachycardia.
• Preeclampsia / severe hypertension – Leads to uteroplacental insufficiency.
• Medications/ Substances – Decongestants (pseudoephedrine), β‑agonists for asthma, caffeine, nicotine, and illicit stimulants.

Fetal causes

• Fetal anemia – Commonly from allo‑immune hemolytic disease (e.g., Rh incompatibility) or maternal infections (parvovirus B19).
• Congenital heart defects – Structural abnormalities can cause compensatory tachycardia.
• Fetal hypoxia – Due to placental insufficiency, cord compression, or maternal respiratory compromise.
• Genetic/metabolic disorders – Rare inborn errors of metabolism that increase basal metabolic rate.

Iatrogenic causes

• Maternal medication – As noted, certain drugs increase fetal catecholamine levels.
• Procedural stimulation – Invasive procedures (amniocentesis, fetal surgery) can transiently raise heart rate.

Risk factor summary

• Maternal age < 20 or > 35 years
• Multiparity with prior pregnancy complications
• Known maternal autoimmune disease (e.g., lupus)
• Pre‑existing cardiac or pulmonary conditions
• Suboptimal prenatal care (delayed infection treatment)

Diagnosis

Diagnosis rests on objective measurement of fetal heart rate and identification of underlying causes.

1. Antepartum monitoring techniques

• Doppler ultrasonography – Hand‑held device used in office visits; a rate >160 bpm lasting >10 minutes suggests tachycardia.
• Cardiotocography (CTG) / Non‑stress test (NST) – Continuous electronic monitoring showing baseline >160 bpm with or without variability.
• Biophysical Profile (BPP) – Combines CTG with ultrasound assessments (movement, tone, fluid) to gauge fetal well‑being.
• Fetal echocardiography – Detailed ultrasound to assess structural heart disease or functional compromise.

2. Maternal evaluations

• Complete blood count (CBC) – Detect anemia, infection.
• Urinalysis & urine culture – Rule out urinary infection.
• Maternal temperature and thyroid function tests.
• Serology for infectious agents (e.g., CMV, parvovirus B19, rubella) when indicated.

3. Laboratory testing of the fetus (when indicated)

• Middle‑cerebral‑artery (MCA) Doppler – Elevated peak systolic velocity suggests fetal anemia.
• Amniocentesis – For karyotype, infection PCR, or fetal blood sampling in severe cases.

Diagnostic criteria

Persistent fetal heart rate ≥ 160 bpm for ≥10 minutes on at least two separate assessments, plus identification of an underlying etiology, constitutes a diagnosis of fetal tachycardia.

Treatment Options

Management is individualized according to gestational age, severity, and the identified cause.

1. Treat the underlying maternal condition

• Infection – Appropriate antibiotics (e.g., ampicillin for UTI) or antiviral therapy.
• Fever – Antipyretics such as acetaminophen (paracetamol) 500‑1000 mg every 6 h, provided no contraindication.
• Hyperthyroidism – Antithyroid drugs (propylthiouracil in 1st trimester, methimazole later) under endocrinology guidance.
• Anemia – Iron supplementation or transfusion if severe; treat allo‑immune anemia with intra‑uterine transfusion.
• Medication review – Discontinue or substitute stimulant drugs after consulting obstetrician.

2. Direct fetal interventions (when fetal compromise is evident)

• Intra‑uterine blood transfusion – For severe fetal anemia, performed under ultrasound guidance.
• Maternal corticosteroids – Accelerate fetal lung maturity if early delivery is anticipated.
• Tocodynamometry – Close monitoring in a high‑risk obstetric unit; sometimes early delivery is safest.

3. Delivery planning

• Induction of labor or cesarean section – Considered when gestational age ≥ 34 weeks with non‑reassuring tracing or after failed intra‑uterine therapy.
• Neonatal resuscitation team present – For pre‑term or compromised fetuses.

4. Supportive measures (lifestyle)

• Maintain maternal hydration and balanced nutrition.
• Avoid excessive caffeine (>200 mg/day) and nicotine.
• Rest in a cool environment if fever present.
• Stress‑reduction techniques (prenatal yoga, breathing exercises) to limit catecholamine surges.

Living with Fetal Tachycardia

While the diagnosis can be anxiety‑provoking, most women can continue a relatively normal pregnancy with careful monitoring.

• Regular prenatal visits – Expect more frequent (often weekly) obstetric appointments and possibly twice‑daily home Doppler checks if instructed.
• Home monitoring – Use a calibrated fetal Doppler; record heart rate and any spikes; share logs with your provider.
• Nutrition – Focus on iron‑rich foods (lean meats, beans, fortified cereals) and adequate folic acid.
• Hydration – Aim for at least 2‑3 L of fluid per day unless restricted for other conditions.
• Pain and fever control – Promptly treat fevers and infections; keep a low‑dose acetaminophen supply.
• Activity – Moderate activity is safe; avoid prolonged standing or overheating.
• Emotional support – Join a support group for high‑risk pregnancies; counseling can reduce stress‑related catecholamine spikes.

Prevention

Because many causes are secondary to maternal health, preventive strategies focus on optimizing the mother’s condition before and during pregnancy.

• Pre‑conception vaccination (influenza, Tdap, COVID‑19) to lower infection risk.
• Screen and treat urinary or respiratory infections promptly.
• Maintain euthyroid state – annual thyroid screening if a history of thyroid disease.
• Manage chronic diseases (diabetes, hypertension) per guidelines (e.g., ADA, ACOG).
• Limit exposure to stimulant substances (caffeine < 200 mg/day, stop smoking, avoid illicit drugs).
• Regular prenatal vitamins containing iron and folic acid.
• Educate on recognizing maternal fever and seeking early care.

Complications

If persistent tachycardia is left untreated, the fetus may experience:

• Fetal hypoxia – Accelerated heart rate can exhaust myocardial oxygen reserves.
• Intra‑uterine growth restriction (IUGR) – Due to chronic placental insufficiency.
• Hydrops fetalis – Severe anemia or cardiac failure leads to fluid accumulation.
• Preterm labor or indicated delivery – Early birth may be required, with associated neonatal risks.
• Neonatal cardiac dysfunction – Especially if structural heart disease is present.

When to Seek Emergency Care

---

References:

1. Mayo Clinic. “Fetal tachycardia.” Accessed March 2024.
2. American College of Obstetricians and Gynecologists (ACOG). Practice Bulletin No. 226: Fetal Heart Rate Monitoring. 2023.
3. Centers for Disease Control and Prevention. “Pregnancy‑related infections.” Updated 2023.
4. National Institutes of Health (NIH). “Maternal hyperthyroidism and fetal outcomes.” 2022.
5. Cleveland Clinic. “Fetal anemia and intra‑uterine transfusion.” 2023.
6. World Health Organization. “Recommendations on antenatal care for a positive pregnancy experience.” 2022.

```